Ecabapide

Ecabapide (DQ 2511) is an orally active gastroprokinetic agent. Ecabapide can ameliorate gastric emptying of stroke-prone spontaneously hypertensive rat model. Ecabapide can be studied in research on autonomic nervous system disorder[1].

Product Specifications

CAS Number

[104775-36-2]

Product Name Alternative

DQ 2511

UNSPSC

12352005

Hazard Statement

H315-H319-H320

Target

Biochemical Assay Reagents

Related Pathways

Others

Applications

Neuroscience-Neuromodulation

Field of Research

Neurological Disease

Smiles

O=C(C1=CC(NCC(NCCC2=CC=C(C(OC)=C2)OC)=O)=CC=C1)NC

Molecular Formula

C20H25N3O4

Molecular Weight

371.43

Precautions

P264-P280-P302+P352-P305+P351+P338-P362

References & Citations

[1]Furuhama K. (1997) . Ecabapide, a novel gastroprokinetic agent, ameliorates gastric emptying of stroke-prone spontaneously hypertensive rats (SHRSP) . The Journal of veterinary medical science, 59 (12), 1153-1155.